SINGAPORE (Reuters) - A company in Singapore has developed a breathalyser test for the new coronavirus which it says will enable people to know whether they are infected in under a minute.
Breathonix, a startup firm from the National University of Singapore, says its test achieved more than 90% accuracy in a pilot clinical trial of 180 people in the city-state and hopes to get regulatory approval early next year.
Already a subscriber? Log in
Get 20% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
